Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking.
Clinical trial NCT00736047 · COMPLETED
Trial details
- NCT number
- NCT00736047
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2009-10-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.